Literature DB >> 34921108

Association of Head Injury With Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Cohort.

Andrea L C Schneider1, Rebecca F Gottesman2, Gregory L Krauss2, James Gugger2, Ramon Diaz-Arrastia2, Anna Kucharska-Newton2, Juebin Huang2, Emily L Johnson2.   

Abstract

BACKGROUND AND OBJECTIVES: Late-onset epilepsy (LOE; i.e., epilepsy starting in later adulthood) affects a significant number of individuals. Head injury is also a risk factor for acquired epilepsy, but the degree to which prior head injury may contribute to LOE is less well understood. Our objective was to determine the association between head injury and subsequent development of LOE.
METHODS: Included were 8,872 participants enrolled in the Atherosclerosis Risk in Communities (ARIC) study with continuous Centers for Medicare Services fee-for-service (FFS) coverage (55.1% women, 21.6% Black). We identified head injuries through 2018 from linked Medicare fee for service claims for inpatient/emergency department care, active surveillance of hospitalizations, and participant self-report. LOE cases through 2018 were identified from linked Medicare FFS claims. We used Cox proportional hazards models to evaluate associations of head injury with LOE, adjusting for demographic, cardiovascular, and lifestyle factors.
RESULTS: The adjusted hazard ratio (HR) for developing LOE after a history of head injury was 1.88 (95% confidence interval [CI] 1.44-2.43). There was evidence for dose-response associations with greater risk for LOE with increasing number of prior head injuries (HR 1.37, 95% CI 1.01-1.88 for 1 prior head injury and HR 3.55, 95% CI 2.51-5.02 for 2+ prior head injuries, compared to no head injuries) and with more severe head injury (HR 2.53, 95% CI 1.83-3.49 for mild injury and HR 4.90, 95% CI 3.15-7.64 for moderate/severe injury, compared to no head injuries). Associations with LOE were significant for head injuries sustained at older age (age ≥67 years: HR 4.01, 95% CI 2.91-5.54), but not for head injuries sustained at younger age (age < 67 years: HR 0.98, 95% CI 0.68-1.41). DISCUSSION: Head injury was associated with increased risk of developing LOE, particularly when head injuries were sustained at an older age, and there was evidence for higher risk for LOE after a greater number of prior head injuries and after more severe head injuries. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that an increased risk of late-onset epilepsy is associated with head injury and that this risk increases further with multiple and more severe head injuries. Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.

Entities:  

Mesh:

Year:  2021        PMID: 34921108      PMCID: PMC8883511          DOI: 10.1212/WNL.0000000000013214

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   11.800


  38 in total

1.  Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.

Authors:  Rebecca F Gottesman; Marilyn S Albert; Alvaro Alonso; Laura H Coker; Josef Coresh; Sonia M Davis; Jennifer A Deal; Guy M McKhann; Thomas H Mosley; A Richey Sharrett; Andrea L C Schneider; B Gwen Windham; Lisa M Wruck; David S Knopman
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

2.  Association Between Midlife Risk Factors and Late-Onset Epilepsy: Results From the Atherosclerosis Risk in Communities Study.

Authors:  Emily L Johnson; Gregory L Krauss; Alexandra K Lee; Andrea L C Schneider; Jennifer L Dearborn; Anna M Kucharska-Newton; Juebin Huang; Alvaro Alonso; Rebecca F Gottesman
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 3.  Epilepsy related to traumatic brain injury.

Authors:  Asla Pitkänen; Riikka Immonen
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

4.  Identification of Heart Failure Events in Medicare Claims: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Anna M Kucharska-Newton; Gerardo Heiss; Hanyu Ni; Sally C Stearns; Nicole Puccinelli-Ortega; Lisa M Wruck; Lloyd Chambless
Journal:  J Card Fail       Date:  2015-07-23       Impact factor: 5.712

Review 5.  Aging and the Epidemiology of Epilepsy.

Authors:  Ettore Beghi; Giorgia Giussani
Journal:  Neuroepidemiology       Date:  2018-09-25       Impact factor: 3.282

6.  Risk of epilepsy after traumatic brain injury: a retrospective population-based cohort study.

Authors:  Chun-Chieh Yeh; Ta-Liang Chen; Chaur-Jong Hu; Wen-Ta Chiu; Chien-Chang Liao
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-10-31       Impact factor: 10.154

7.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

8.  Mild Cognitive Impairment and Dementia Prevalence: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).

Authors:  David S Knopman; Rebecca F Gottesman; A Richey Sharrett; Lisa M Wruck; B Gwen Windham; Laura Coker; Andrea Lc Schneider; Sun Hengrui; Alvaro Alonso; Josef Coresh; Marilyn S Albert; Thomas H Mosley
Journal:  Alzheimers Dement (Amst)       Date:  2016

9.  Head injury and 25-year risk of dementia.

Authors:  Andrea L C Schneider; Elizabeth Selvin; Lawrence Latour; L Christine Turtzo; Josef Coresh; Thomas Mosley; Geoffrey Ling; Rebecca F Gottesman
Journal:  Alzheimers Dement       Date:  2021-03-09       Impact factor: 16.655

10.  Incidence rate estimation, periodic testing and the limitations of the mid-point imputation approach.

Authors:  Alain Vandormael; Adrian Dobra; Till Bärnighausen; Tulio de Oliveira; Frank Tanser
Journal:  Int J Epidemiol       Date:  2018-02-01       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.